Both in Pharmaceuticals
Alkermes vs Rhythm Pharmaceuticals
Over the past year ALKS returned +46.8% and RYTM returned −20.0%; their daily moves had a correlation of 0.41.
ALKS +46.8% RYTM −20.0%Growth of $1, one year, split-adjusted
| Metric | ALKS | RYTM |
|---|---|---|
| Price | $43.63 | $89.27 |
| Market cap | $7.32B | $6.15B |
| Today | −1.24% | −1.79% |
| 1 month | +7.0% | −9.2% |
| 6 months | +31.0% | +4.2% |
| Year to date | +55.9% | −16.6% |
| 1 year | +40.3% | −18.2% |
| Revenue growth (YoY) | +27.0% | +46.9% |
| Gross margin | 80.2% | 87.5% |
| Net margin | 0.1% | −70.7% |
| P/E (TTM) | 110.7× | — |
| Price / sales | 4.4× | 25.6× |
| Net cash | -$846.5M | $224.8M |
| Dividend yield | — | — |
| Volatility (60d) | 31.8% | 36.2% |
| Short % of float | 10.8% | 16.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).